MYT1
Basic information
Region (hg38): 20:64102394-64242253
Previous symbols: [ "PLPB1" ]
Links
Phenotypes
GenCC
Source:
- craniofacial microsomia (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (112 variants)
- MYT1-related_disorder (33 variants)
- not_provided (30 variants)
- Intellectual_disability (4 variants)
- Hereditary_spastic_paraplegia (1 variants)
- Autism_spectrum_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYT1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004535.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 28 | 33 | ||||
missense | 112 | 10 | 126 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 1 | 112 | 38 | 8 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYT1 | protein_coding | protein_coding | ENST00000328439 | 21 | 90461 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.978 | 0.0221 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.56 | 489 | 677 | 0.723 | 0.0000418 | 7370 |
Missense in Polyphen | 174 | 306.32 | 0.56803 | 3256 | ||
Synonymous | 0.607 | 272 | 285 | 0.954 | 0.0000201 | 2139 |
Loss of Function | 5.68 | 10 | 55.8 | 0.179 | 0.00000301 | 652 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000370 | 0.000366 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000623 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to the promoter region of genes encoding proteolipid proteins of the central nervous system. May play a role in the development of neurons and oligodendroglia in the CNS. May regulate a critical transition point in oligodendrocyte lineage development by modulating oligodendrocyte progenitor proliferation relative to terminal differentiation and up- regulation of myelin gene transcription. {ECO:0000269|PubMed:14962745}.;
- Pathway
- MECP2 and Associated Rett Syndrome;G1 to S cell cycle control;cdc25 and chk1 regulatory pathway in response to dna damage;how progesterone initiates the oocyte maturation;cell cycle: g2/m checkpoint;rb tumor suppressor/checkpoint signaling in response to dna damage
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.220
- rvis_EVS
- -1.63
- rvis_percentile_EVS
- 2.85
Haploinsufficiency Scores
- pHI
- 0.938
- hipred
- Y
- hipred_score
- 0.755
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.988
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Myt1
- Phenotype
- muscle phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- myt1b
- Affected structure
- pancreatic A cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;nervous system development;cell differentiation;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;cytosol
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;zinc ion binding